Australia's largest stock trading and investment forum Australia's #1 stock forum

RGS

Click for more information

0.00%

12.0¢ regeneus ltd

Well that didn’t take long to smash through the 20c roadblock!

First 36 Last

Share
Profile

Follow
TDA

10,917 Posts.

69

23/07/18

10:23

Post #: 34514391
Share

Originally posted by Biotechasx ↑

Well said TDA. I joined in very early for the very same reasons and certainly consider a future SP in dollars not cents as a probability not a dream. The timing is the main question here.

We all know the difficulty to both execute a great R&D/Commercialisation plan and to deliver value for SH at the same time. It's tough for very small caps, especially in biotech and in Australia. Being able to manage long term and short term expectations is an art.

In a way, the success of Viralytics has given me some hope that RGS's value could be soon recognised by either the stock market or a buyer.
The reason is very simple: if the announced strategy for Progenza is delivered on time (i.e. patents, commercial partnerships, milestones payments, trials and sales), then it opens a very straight forward and efficient pathway to market for Sygenus, which has even more potential that Progenza.

In the meantime, it is a pleasure to finally see a nice ride on the back of the so-important granted patent in the US.
When a commercial partnership is finally announced for Progenza in Japan, I think SP will reach 0.35 easily if not 0.5.
For 0.7/0.8 will have to wait a bit longer.

Expand

Well that didn’t take long to smash through the 20c roadblock!

RGS Price at posting: 20.5¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

RSG

Resolute shares bounce back as second payment made to Mali government to secure workers' release

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

HotCopper Highlights: Your most watched stocks for Week 48, 2024

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

ADD

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

There are more pages in this discussion • 58 more messages in this thread...

First 36 Last

Add RGS (ASX) to my watchlist